| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | IRONWOOD PHARMACEUTICALS INC COM CL A | 2,061,417 | 22,552,000 | 7.88% | ||
| 2 | FIVE PRIME THERAPEUTICS INC | 500,757 | 20,346,000 | 7.11% | ||
| 3 | EPIZYME INC COM | 1,598,900 | 19,379,000 | 6.77% | ||
| 4 | FIBROGEN INC COM | 863,745 | 18,389,000 | 6.43% | ||
| 5 | ARRAY BIOPHARMA INC 3 06/01/2020 | 22,534,000 | 18,140,000 | 6.34% | PRN | |
| 6 | RETROPHIN INC COM | 1,225,084 | 16,735,000 | 5.85% | ||
| 7 | SPDR SERIES TRUST | 297,200 | 15,353,000 | 5.36% | Call | |
| 8 | CYTOKINETICS INC | 2,052,800 | 14,472,000 | 5.06% | ||
| 9 | GILEAD SCIENCES INC | 150,000 | 13,779,000 | 4.81% | Call | |
| 10 | ASSEMBLY BIOSCIENCES INC | 2,098,302 | 10,533,000 | 3.68% | ||
| 11 | CELATOR PHARMACEUTICALS INC | 950,000 | 10,479,000 | 3.66% | ||
| 12 | GALAPAGOS NV | 246,691 | 10,317,000 | 3.60% | ||
| 13 | KURA ONCOLOGY INC | 2,465,286 | 9,984,000 | 3.49% | ||
| 14 | COLLEGIUM PHARMACEUTICAL INC COM | 473,123 | 8,587,000 | 3.00% | ||
| 15 | ACCELERON PHARMA | 270,289 | 7,133,000 | 2.49% | ||
| 16 | AIMMUNE THERAPEUTICS INC COM | 521,366 | 7,070,000 | 2.47% | ||
| 17 | ENANTA PHARMACEUTICALS INC COM | 240,383 | 7,060,000 | 2.47% | ||
| 18 | KITE PHARMA INCORPORATED | 150,000 | 6,887,000 | 2.41% | ||
| 19 | Syndax Pharmaceuticals Inc | 510,829 | 6,804,000 | 2.38% | ||
| 20 | Nabriva Therapeutics AG | 707,817 | 6,342,000 | 2.22% | ||
| 21 | FLEX PHARMA INC COM | 575,925 | 6,318,000 | 2.21% | ||
| 22 | KINDRED BIOSCIENCES INC | 1,432,765 | 4,943,000 | 1.73% | ||
| 23 | LOXO ONCOLOGY INC COM | 150,308 | 4,109,000 | 1.44% | ||
| 24 | IRONWOOD PHARMACEUTICALS INC | 300,000 | 3,282,000 | 1.15% | Call | |
| 25 | EIGER BIOPHARMACEUTICALS INC | 189,545 | 3,179,000 | 1.11% | ||
| 26 | EDITAS MEDICINE INCORPORATED | 87,921 | 3,037,000 | 1.06% | ||
| 27 | IMMUNOGEN INC | 299,500 | 2,552,000 | 0.89% | Call | |
| 28 | CYTOKINETICS INC | 250,000 | 1,763,000 | 0.62% | Call | |
| 29 | FORWARD PHARMA A/S | 97,024 | 1,649,000 | 0.58% | ||
| 30 | ARRAY BIOPHARMA INC | 520,000 | 1,534,000 | 0.54% | Call | |
| 31 | AKARI THERAPEUTICS PLC | 92,303 | 1,292,000 | 0.45% | ||
| 32 | TARGACEPT INC | 669,166 | 669,000 | 0.23% | PRN | |
| 33 | BEIGENE LTD | 15,766 | 462,000 | 0.16% | ||
| 34 | GLOBAL BLOOD THERAPEUTICS IN COM | 28,032 | 445,000 | 0.16% | ||
| 35 | Life Technologies Corp | 74,959 | 295,000 | 0.10% | ||
| 36 | SPARK THERAPEUTICS INC | 8,700 | 257,000 | 0.09% | ||
| 37 | ZAFGEN INC | 10,000 | 67,000 | 0.02% | Call |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001140361-16-065705, filed 2016.05.16).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
